Respiratory Care Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By End User, By Region & Competition, 2021-2031F

The Global Respiratory Care Devices Market is projected to expand significantly, rising from USD 18.92 Billion in 2025 to USD 31.07 Billion by 2031, reflecting a compound annual growth rate of 8.62%. This sector encompasses a wide variety of medical equipment utilized for the diagnosis, monitoring, and treatment of cardiopulmonary disorders, with growth primarily fueled by the increasing global incidence of chronic ailments like asthma and chronic obstructive pulmonary disease. Highlighting the impact of environmental factors, the American Lung Association reported in 2024 that nearly 131 million individuals in the United States resided in areas with hazardous air pollution levels, a condition that worsens lung health and sustains the demand for supplemental oxygen and bronchial hygiene tools.

Despite these positive indicators, the market faces a substantial obstacle due to the high acquisition costs associated with sophisticated ventilation and monitoring equipment. Financial limitations within healthcare systems, particularly in developing nations, often hinder the procurement of these vital devices, thereby restricting patient access to essential care. Furthermore, inconsistent reimbursement frameworks for home-based respiratory services introduce financial unpredictability for both healthcare providers and patients, which can delay the widespread adoption of newer therapeutic methods in regions that are sensitive to price fluctuations.

Market Driver

The surging global prevalence of chronic and infectious respiratory illnesses acts as the primary force accelerating the respiratory care devices market. As pollution and airborne pathogens increasingly compromise lung function worldwide, the demand for reliable diagnostic and therapeutic interventions has intensified, especially for conditions requiring prolonged management. This growing disease burden necessitates that healthcare systems augment their inventories of airway management and oxygen therapy equipment to accommodate the rising number of patients requiring critical support, a need underscored by the World Health Organization's 'Global Tuberculosis Report 2024', which estimated that 10.8 million people fell ill with tuberculosis globally in 2023.

In parallel, there is a marked increase in the demand for remote monitoring and home-based respiratory care, which is fundamentally transforming service delivery. Patients and medical providers are gravitating towards smart, portable devices that enable continuous therapy outside of conventional hospital environments, aiming to lower readmission rates and improve quality of life. This shift towards residential treatment is reflected in the financial results of key industry players; Fisher & Paykel Healthcare reported an 18% revenue increase in their Homecare product group in 2024, while ResMed saw a 9% rise in quarterly revenue, confirming the continued investment in advanced, home-focused respiratory care ecosystems.

Market Challenge

A major impediment to the growth of the global respiratory care devices market is the steep cost associated with acquiring advanced monitoring and ventilation technologies. This economic barrier significantly curtails the ability to procure necessary medical equipment, particularly in developing countries where healthcare infrastructure is often underfunded. Consequently, the inability to purchase these critical devices restricts patient access to essential treatments and decelerates the wider adoption of innovative therapeutic solutions in regions that are highly sensitive to pricing pressures.

Additionally, the immense economic strain caused by respiratory diseases places further pressure on healthcare budgets, leaving few resources available for investing in expensive equipment upgrades. According to the European Respiratory Society, the annual societal cost of lung health in the European Union hit €422 billion in 2024, a massive financial burden that generates uncertainty for providers and complicates reimbursement structures. As a result, market expansion is often stalled in key territories as healthcare systems struggle to balance the escalating costs of disease management with the necessity for advanced technological solutions.

Market Trends

The application of Artificial Intelligence and Machine Learning for predictive diagnostics is gaining significant traction within the respiratory sector, driven by major capital investments in technologies that automate the analysis of lung imaging and respiratory biometrics. This trend involves the creation of advanced algorithms capable of detecting early-stage malignancies and tuberculosis with greater accuracy than manual methods, thereby attracting strong investor confidence in their potential to improve clinical outcomes. Demonstrating this financial momentum, Qure.ai secured $65 million in Series D funding in September 2024 to expedite the expansion of its AI-driven lung health solutions into the US market, confirming the high industry value placed on automated diagnostic capabilities.

Simultaneously, the integration of IoT and smart connectivity into respiratory devices is transforming the market by establishing interoperable care ecosystems that link hardware directly with clinical oversight platforms. Manufacturers are progressively embedding high-fidelity data transmission modules into patient monitors and ventilators to enable continuous, remote observation of respiratory mechanics, which significantly enhances hospital workflow and patient safety. This strategic emphasis on networked solutions is supported by recent financial data from Royal Philips, which reported a 5% increase in comparable sales for its Connected Care segment in 2023, driven by double-digit growth in its hospital patient monitoring portfolio.

Key Market Players

• Dragerwerk AG & Co. KGaA
• Fisher & Paykel Healthcare Limited
• General Electric Company
• Getinge AB
• Inogen, Inc.
• Masimo
• Medtronic
• Koninklijke Philips N.V.
• ResMed
• VYAIRE

Report Scope

In this report, the Global Respiratory Care Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Respiratory Care Devices Market, By Product

• Therapeutic Devices
• Monitoring Devices
• Consumables
• Accessories

Respiratory Care Devices Market, By End User

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Others

Respiratory Care Devices Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Respiratory Care Devices Market.

Available Customizations:

Global Respiratory Care Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).